JP2022540433A - カンナビノイド誘導体 - Google Patents
カンナビノイド誘導体 Download PDFInfo
- Publication number
- JP2022540433A JP2022540433A JP2022500796A JP2022500796A JP2022540433A JP 2022540433 A JP2022540433 A JP 2022540433A JP 2022500796 A JP2022500796 A JP 2022500796A JP 2022500796 A JP2022500796 A JP 2022500796A JP 2022540433 A JP2022540433 A JP 2022540433A
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pentyl
- trimethyl
- chromen
- benzo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962873697P | 2019-07-12 | 2019-07-12 | |
| US62/873,697 | 2019-07-12 | ||
| PCT/CA2020/050965 WO2021007659A1 (en) | 2019-07-12 | 2020-07-10 | Cannabinoid derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022540433A true JP2022540433A (ja) | 2022-09-15 |
| JP2022540433A5 JP2022540433A5 (enExample) | 2025-02-14 |
Family
ID=74209629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500796A Ceased JP2022540433A (ja) | 2019-07-12 | 2020-07-10 | カンナビノイド誘導体 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220242856A1 (enExample) |
| EP (1) | EP3997084A4 (enExample) |
| JP (1) | JP2022540433A (enExample) |
| WO (1) | WO2021007659A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3994114A4 (en) | 2019-07-04 | 2023-08-16 | Canopy Growth Corporation | CANNABINOID DERIVATIVES |
| WO2021007663A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| EP3997098A4 (en) | 2019-07-12 | 2023-10-11 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021007661A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| JP2022551066A (ja) | 2019-10-02 | 2022-12-07 | キャノピー グロウス コーポレイション | カンナビノイド誘導体 |
| WO2021062557A1 (en) * | 2019-10-02 | 2021-04-08 | Canopy Growth Corporation | Cannabinoid derivatives |
| US12084407B2 (en) | 2019-11-26 | 2024-09-10 | Canopy Growth Corporation | Cannabigerol derivatives and use thereof as cannabinoid receptor modulators |
| US12617765B2 (en) | 2019-12-09 | 2026-05-05 | Canopy Growth Corporation | Cannabinoid derivatives |
| IL312785B2 (en) | 2020-05-19 | 2026-06-01 | Cybin Irl Ltd | Deuterated tryptamine derivatives and methods of use |
| AU2021400338A1 (en) | 2020-12-17 | 2023-07-13 | Nalu Bio, Inc. | Synthesis of cannabidiol and analogs thereof, and related compounds, formulations, and methods of use |
| EP4436559A4 (en) | 2021-11-27 | 2025-04-02 | Miralogx LLC | SYNTHETIC CANNABINOID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENT |
| US12636296B1 (en) | 2025-07-17 | 2026-05-26 | Nalu Bio, Inc. | Cannabinol analogs and their use as pharmacologically active agents |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3325490A (en) * | 1965-02-23 | 1967-06-13 | Rexall Drug Chemical | Substituted 1-hydroxydibenzopyrans |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080064679A1 (en) * | 2004-06-24 | 2008-03-13 | Martin Billy R | Water Soluble Cannabinoids |
| AU2007248760A1 (en) * | 2006-05-01 | 2007-11-15 | Eastern Virginia Medical School | Novel cannabinoids and methods of use |
| WO2019234728A1 (en) * | 2018-06-04 | 2019-12-12 | Al&Am Pharmachem Ltd. | Cannabinolic acid derivatives and uses thereof |
-
2020
- 2020-07-10 WO PCT/CA2020/050965 patent/WO2021007659A1/en not_active Ceased
- 2020-07-10 JP JP2022500796A patent/JP2022540433A/ja not_active Ceased
- 2020-07-10 EP EP20838885.0A patent/EP3997084A4/en active Pending
- 2020-07-10 US US17/626,512 patent/US20220242856A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3325490A (en) * | 1965-02-23 | 1967-06-13 | Rexall Drug Chemical | Substituted 1-hydroxydibenzopyrans |
Non-Patent Citations (2)
| Title |
|---|
| "CAS登録番号 2062397-07-1 他７化合物", REGISTRY（STN）[ONLINE], JPN7024003283, 2017, ISSN: 0005386293 * |
| ZEHAVI, URI; MECHOULAM, RAPHAEL: "O- and C-D-glucosyluronic acid derivatives of Δ1-tetrahydrocannabinol: synthesis and differential", CARBOHYDRATE RESEARCH, vol. 98(1), JPN6024030837, 1981, pages 143 - 7, ISSN: 0005386294 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3997084A4 (en) | 2023-06-07 |
| US20220242856A1 (en) | 2022-08-04 |
| WO2021007659A1 (en) | 2021-01-21 |
| EP3997084A1 (en) | 2022-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2021007659A1 (en) | Cannabinoid derivatives | |
| US12195429B2 (en) | Cannabinoid derivatives | |
| JP2023503331A (ja) | カンナビノイド誘導体 | |
| JP7684945B2 (ja) | カンナビノイド誘導体 | |
| EP3997095B1 (en) | Cannabinoid derivatives | |
| US12252503B2 (en) | Cannabinoid derivatives | |
| JP2022551067A (ja) | カンナビノイド誘導体 | |
| JP2022539400A (ja) | カンナビノイド誘導体 | |
| JP2022539401A (ja) | カンナビノイド誘導体 | |
| JP2023505513A (ja) | カンナビノイド誘導体 | |
| US12617765B2 (en) | Cannabinoid derivatives | |
| JP2023503601A (ja) | カンナビゲロール誘導体、およびカンナビノイド受容体モジュレーターとしてのその使用 | |
| JP2022551066A (ja) | カンナビノイド誘導体 | |
| JP2023503330A (ja) | カンナビノイド誘導体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230705 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230705 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20240725 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240806 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20241028 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20250205 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250415 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20250515 |
|
| A045 | Written measure of dismissal of application [lapsed due to lack of payment] |
Free format text: JAPANESE INTERMEDIATE CODE: A045 Effective date: 20250826 |